🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study was to provide required access of invest...
Status
Completed
Location
Research Site
Start Date
2014-06-12
Trial ID
NCT02175277
Treatments Being Tested
This study will compare the efficacy (non-inferiority) of darbepoetin alfa ...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00144131
Treatments Being Tested
To deterime the efficacy of 500 μg and 300 μg darbepoetin alfa administered...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00401544
Treatments Being Tested
This study will assess the comfort of subcutaneous injections of NeoRecormo...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00377481
Treatments Being Tested
The purpose of this study is to evaluate the response rate obtained in an h...
Status
Terminated
Location
Centre Hospitalier de Castres
Start Date
2003-11
Trial ID
NCT00210002
Treatments Being Tested
This study was conducted to explore a new therapy for anemia in participant...
Status
Completed
Location
Site BE32004
Start Date
2014-11-21
Trial ID
NCT02278341
Treatments Being Tested
This is a randomized double-blind crossover study of pharmacokinetics, phar...
Status
Completed
Location
City Mariin Hospital
Start Date
2013-03
Trial ID
NCT02506881
Treatments Being Tested
This is a web-based pilot study to evaluate the association between the tre...
Status
Completed
Location
Norris Cotton Cancer Center
Start Date
2003-10
Trial ID
NCT00153868
Treatments Being Tested
The purpose of this study is to compare the pharmacokinetics and safety aft...
Status
Completed
Location
Samsung Medical Center
Start Date
2014-10
Trial ID
NCT03542916
Treatments Being Tested
The purpose of this study was to evaluate Aranesp® administered subcutaneou...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00117065
Treatments Being Tested